Log In
Print
BCIQ
Print
Print this Print this
 

Cu-64-TP3805 (NVB-64)

  Manage Alerts
Collapse Summary General Information
Company NuView Life Sciences Inc.
DescriptionAdenylate cyclase activating polypeptide pituitary (ADCYAP1; PACAP) analog TP3805 labeled with Cu-64
Molecular Target Vasoactive intestinal peptide receptor 1 (VPAC1)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationCancer, Diagnostic
Indication DetailsDetect malignant breast tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today